Evidence map›Paper›PMID 34966443›Full record

ArticleComputational and mathematical methods in medicine2021

The Levels of Amyloid

Chenyu Xia, Qiang Ma

RetractedOpen access · hybridAbstract readRetracted Publication
PubMed Full text at PMC Publisher
In one paragraph

Article in Computational and mathematical methods in medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Retracted: The Levels of AmyloidComputational and mathematical methods in medicine · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Chenyu XiaDepartment of Neurology, Affiliated Zhongshan Hospital of Dalian University, Dalian 116001, China.
Qiang MaDepartment of Neurology, Affiliated Zhongshan Hospital of Dalian University, Dalian 116001, China.ORCID https://orcid.org/0000-0003-4578-2889
Affiliated Zhongshan Hospital of Dalian University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo analyze the levels of amyloid

methodFrom January 2019 to June 2020, 59 patients were enrolled in this experiment including the AD group with 27 patients and the normal control group with 32 patients. The patients were divided into two groups: Alzheimer's disease (AD) group (

resultSingle diagnostic sensitivity of A

conclusionThere are significant alterations in the expression levels of A

Indexed as

Helicobacter pyloriAgedAged, 80 and overAlzheimer DiseaseAmyloid beta-PeptidesBiomarkersCase-Control StudiesComputational BiologyFemaleHelicobacter InfectionsHumansMaleMiddle AgedPeptide FragmentsPhosphorylationPrognosisAmyloid beta-Peptidesamyloid beta-protein (1-42)BiomarkersMAPT protein, humanPeptide Fragmentstau Proteins

Identifiers

PMID34966443
PMCPMC8712151
OpenAlexW4200616802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.